About this trial
The study aims to investigate the effects of percussion therapy and instrument-assisted soft tissue mobilization (AISM), commonly used in clinical settings, on muscle fatigue, maximum muscle strength, pain threshold, and muscle oxygenation.
The study will involve 20 volunteer participants. To achieve the study results, pre-exercise percussion therapy and instrument-assisted soft tissue mobilization (AISM) will be administered using a crossover design.
Results will be measured using a digital dynamometer, a moxy oxygen monitor, and a fatigue questionnaire.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Aged 18-35 years
Healthy participants
Sedentary lifestyle as defined by the International Physical Activity Questionnaire (IPAQ) (low physical activity category)
Ability to understand the study procedures and provide written informed consent
Disqualifiers
Upper extremity injury or surgery within the past 6 months
Presence of skin lesions, wounds, or dermatological diseases at the application site
Any diagnosed musculoskeletal disorder
History of cardiovascular, metabolic, or pulmonary disease
Trial design
Crossover
Treatments tested in this trial
Percussion Therapy
Other interventionThe massage gun will operate at a frequency of 30 beats per second (30 Hz), and percussion therapy will be applied to the muscle for 2 minutes. Percussion therapy will be performed using the device's standard ball head. The force applied by the device will be fixed so that it does not exceed the device's first-stage force setting (approximately 30 pounds). The biceps brachii (dominant arm) will be treated for 2 minutes at 30 Hz, moderate intensity.
Instrument-Assisted Soft Tissue Mobilization (AISM)
Other interventionThe arm will be positioned at the edge of the bed in full extension, with the shoulder in 45-degree abduction. The examiner will apply gentle pressure using a 30-degree angled instrument at a rate of 120 strokes/min, aligning the instrument's weight with the fibers of the biceps brachii muscle. The examiner will use a metronome to maintain a consistent pace during treatment, and the instrument angle will be calibrated with a protractor before each subject's treatment. The procedure will last 2 minutes, and baby oil will be used to ensure the instrument moves smoothly over the skin.
Treatment groups
Trial outcomes
Primary outcomes
Muscle Oxygen Saturation (SmO₂)
Oxygen saturation will be measured with the MOXY device. It is an infrared measuring device called "near infrared spectroscopy" that measures oxygen saturation and total hemoglobin in muscle capillaries. The device will be attached to the highest point of the muscle and secured with a black sheath and tape to prevent light exposure.
Secondary outcomes
Muscle Strength
Subjects will be seated with the elbow joint flexed to 90°, forearm in supination. They will be asked to contract their muscles in the direction of elbow flexion for 5 seconds, and the physiotherapist will apply force in the opposite direction to prevent movement in the elbow joint. Three measurements will be taken 30 seconds apart, and the average will be recorded.
Other outcomes
Pain Threshold
Measurements will be taken at the same point for all participants while the subjects lie supine, with the forearm in full supination at the side of the body and the elbow in full extension. A control trial will be conducted before the measurement, and participants will be instructed to say "OK" as soon as they feel pain
Perceived Fatigue
This is a scale used to assess the degree of exertion felt by the participant after exercise. The Borg Scale allows the participant to express the fatigue felt during exercise on a scale of none (6), very light (7-8), light (9-10), fairly light (11-12), somewhat difficult (13-14), difficult (15-16), very difficult (17-18), very very difficult (19), and exhaustion (20)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: